UNESCO Together with Merck Foundation will continue to build research capacity in the African Research Community in the fields of science and sustainability
Merck Foundation, the philanthropic arm of Merck Germany plans to conduct the New Edition of their “UNESCO – Merck Africa Research Summit (MARS) 2019” in partnership with African Union in ACCRA, GHANA on 30th of October 2019 during their annual conference “Merck Africa Asia Luminary”.
Dr. Rasha Kelej, CEO of Merck Foundation and Chairperson of UNESCO-MARS explained “The Summit aims to contribute to building research capacity in African research community and discuss challenges, opportunities & proposed strategies to support health decision making that address Health and Sustainability challenges in low-and middle-income countries. The end objective is to empower African young researchers & women researchers, advancing their research capacity and promote their contribution to STEM”.
The scientific committee of the UNESCO MARS 2019 include Dr. Rasha Kelej, CEO of Merck Foundation & Chairperson of UNESCO-MARS; Mr. Diallo Abdourahamane, UNESCO Director to Ghana; Dr. Ahmed Fahmi, Chief of Section, Division of Science Policy and Capacity Building, UNESCO; Dr. Ahmed Hamdy, African Union - Scientific, Technical and Research Commission and Prof. Elijah Songkok, Assistant Professor, Department of Medical Microbiology and Infectious Diseases College of Medicine, University of Manitoba, Kenya.
High Level Ministerial Panel
The UNESCO MARS 2019 will host high level participants that include many African Ministers of Health, Science and Technology, Education, information and Gender and African Researchers.
“This high-level roundtable meeting will also provide networking opportunities to strengthen the research community and their impact on African society and media communication” concluded Dr. Rasha Kelej.
One Click on icon below to
Download Merck Foundation App
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.